Biocon Limited has informed the Exchange regarding a press release dated February 28, 2025, titled "Biocon Limited launches its Glucagon-like peptide-1 (GLP -1), Liraglutide, in the United Kingdom".
Biocon Limited has informed the Exchange regarding a press release dated February 28, 2025, titled "Biocon Limited launches its Glucagon-like peptide-1 (GLP -1), Liraglutide, in the United Kingdom".